Blueprint maps plans for $150M raise; GlaxoSmithKline creates discovery pact with Warp Drive
→ Blueprint Medicines $BPMC has filed to raise $150 million in a new stock offering. Most of the new money is being earmarked for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
